Task Force Mammography Guidelines Present Challenges And Opportunities
This article was originally published in The Gray Sheet
Mammography coverage policies among public and private payers are not likely to be restricted, at least in the near term, by the U.S. Preventive Services Task Force's new breast cancer screening guidelines, but prospects for longer-term adjustments remain
You may also be interested in...
FDA’s Center for Devices and Radiological Health will gain $3 million more in funding compared to 2015, NIH will get a $2 billion boost, and Precision Medicine and BRAIN initiatives will be well-funded under a budget agreement reached by Congress Dec. 15, slated for Congress’ approval in the next several days.
The American Cancer Society’s Oct. 20 update to breast cancer screening guidelines for mammograms starting at age 45, rather than its prior recommendation to start at age 40, for average risk women conflicts with other groups’ recommendations, is confusing and potential “risky”, say the imaging industry and some medical groups.
In a draft recommendation, the U.S. Preventive Services Task Force says evidence is "insufficient" to assess 3D tomosynthesis for breast cancer screening, as well as for additional dense-breast screening by any modality.